SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: C. K. Humphries who wrote (3514)4/21/1998 2:45:00 PM
From: Linda Kaplan  Read Replies (2) of 7041
 
Hi, Kent,

You make good points. I believe you're right that people were excluded who had serious side effects. Also if Vasomax were ever approved, people wouldn't use it who are really happy with Viagra. So that would reduce the efficacy percentage by quite a bit.

ZONA is doing amazingly. The longs are making a ton of money, even though there's nothing but hype about the company. No one can argue with success, certainly I can't. This stock is doing well, even if the company will probably fail.

Thanks for the nice note. It's a relief to hear from reasonable people again.

By the way, did everyone notice that a lot of companies came out with above-expected earnings, like BMY, for example, but that SGP came out below expectations?

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext